The PRESBYLENS™ Corneal Inlay (CI) is a unique, patented refractive surgery solution that is designed to correct vision lost by the natural aging process called presbyopia.

The PRESBYLENS™ CI, made from our proprietary microporous hydrogel material, is designed to be removable, adjustable and improve near vision with little or no compromise at distance.

The potential result is a significantly less risky and better-suited treatment of presbyopia than subtractive technologies such as LASIK.

ReVision Optics™, Inc., is a privately held corporation headquartered in Southern California.


Date Type Amount Investors Valuation
04/01/07 Series D 25M Domain Associates, Canaan Partners, InterWest Partners Unknown


Audrey Munnerlyn (VP Regulatory & Quality Affairs)

Brian Hovey (Board Member)

Randy Alexander (President/CEO)

Louis Bunn (CFO)

Ali Dahi (VP Process Development)

View more details about all 12 people at ReVision Optics